201 related articles for article (PubMed ID: 24919615)
1. Sodium butyrate protects against toxin-induced acute liver failure in rats.
Yang F; Wang LK; Li X; Wang LW; Han XQ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2014 Jun; 13(3):309-15. PubMed ID: 24919615
[TBL] [Abstract][Full Text] [Related]
2. Ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats with D-galactosamine-induced acute liver failure.
Wang LK; Wang LW; Li X; Han XQ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):180-8. PubMed ID: 23558073
[TBL] [Abstract][Full Text] [Related]
3. Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats.
Zhang Y; Luo JX; Hu XY; Yang F; Zhong S; Lin W
World J Gastroenterol; 2016 Feb; 22(8):2558-65. PubMed ID: 26937143
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic effect of CORM-3 on acute liver failure induced by lipopolysaccharide/D-galactosamine in mice.
Yan BZ; Yang BS; Li H; Zhang YF; Pei FH; Zhu AC; Wang XR; Liu BR
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):73-80. PubMed ID: 26818546
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of sphingosine kinase 1 ameliorates acute liver failure by reducing high-mobility group box 1 cytoplasmic translocation in liver cells.
Lei YC; Yang LL; Li W; Luo P; Zheng PF
World J Gastroenterol; 2015 Dec; 21(46):13055-63. PubMed ID: 26676341
[TBL] [Abstract][Full Text] [Related]
6. Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats.
Wang LW; Wang LK; Chen H; Fan C; Li X; He CM; Gong ZJ
World J Gastroenterol; 2012 Oct; 18(40):5709-18. PubMed ID: 23155311
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine kinase 1 dependent protein kinase C-δ activation plays an important role in acute liver failure in mice.
Lei YC; Yang LL; Li W; Luo P
World J Gastroenterol; 2015 Dec; 21(48):13438-46. PubMed ID: 26730154
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of the pretreatment and treatment with RhIL-11 on acute liver failure induced by D-galactosamine.
Nie XH; Han T; Ha FU; Liang N; Wang SH; Zhu ZY; Xiang HL
Eur Rev Med Pharmacol Sci; 2014; 18(8):1142-50. PubMed ID: 24817287
[TBL] [Abstract][Full Text] [Related]
10. Effect of bone marrow mesenchymal stem cells transplantation on the serum and liver HMGB1 expression in rats with acute liver failure.
Zheng S; Yang J; Tang Y; Yang J; Shao Q; Guo L; Liu Q
Int J Clin Exp Pathol; 2015; 8(12):15985-92. PubMed ID: 26884873
[TBL] [Abstract][Full Text] [Related]
11. Gensenoside Rg1 protects against lipopolysaccharide- and d-galactose-induced acute liver failure via suppressing HMGB1-mediated TLR4-NF-κB pathway.
Jin H; Jiang Y; Lv W; Chen L; Zheng Y; Lin Y
Mol Cell Probes; 2021 Apr; 56():101706. PubMed ID: 33617946
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin tolerance alleviates experimental acute liver failure via inhibition of high mobility group box 1.
Yang NB; Ni SL; Li SS; Zhang SN; Hu DP; Lu MQ
Int J Clin Exp Pathol; 2015; 8(8):9062-71. PubMed ID: 26464648
[TBL] [Abstract][Full Text] [Related]
13. Blockade of high-mobility group box-1 ameliorates acute on chronic liver failure in rats.
Li X; Wang LK; Wang LW; Han XQ; Yang F; Gong ZJ
Inflamm Res; 2013 Jul; 62(7):703-9. PubMed ID: 23591781
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human soluble thrombomodulin improved lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
Osumi W; Jin D; Imai Y; Tashiro K; Li ZL; Otsuki Y; Maemura K; Komeda K; Hirokawa F; Hayashi M; Takai S; Uchiyama K
J Pharmacol Sci; 2015 Dec; 129(4):233-9. PubMed ID: 26712705
[TBL] [Abstract][Full Text] [Related]
15. Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice.
Xie J; Liu J; Chen TM; Lan Q; Zhang QY; Liu B; Dai D; Zhang WD; Hu LP; Zhu RZ
World J Gastroenterol; 2015 May; 21(18):5473-81. PubMed ID: 25987769
[TBL] [Abstract][Full Text] [Related]
16. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
[TBL] [Abstract][Full Text] [Related]
17. Lipoxin A4 exerts protective effects against experimental acute liver failure by inhibiting the NF-κB pathway.
Jiang X; Li Z; Jiang S; Tong X; Zou X; Wang W; Zhang Z; Wu L; Tian D
Int J Mol Med; 2016 Mar; 37(3):773-80. PubMed ID: 26865215
[TBL] [Abstract][Full Text] [Related]
18. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
[TBL] [Abstract][Full Text] [Related]
19. The effects of modified sini decoction on liver injury and regeneration in acute liver failure induced by D-galactosamine in rats.
Luo J; Zhang Y; Hu X; Zhong S; Chen G; Wang Y; Lin W; Yi C; Zhu H
J Ethnopharmacol; 2015 Feb; 161():53-9. PubMed ID: 25499312
[TBL] [Abstract][Full Text] [Related]
20. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
